Page last updated: 2024-08-24

aripiprazole and Nausea

aripiprazole has been researched along with Nausea in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (61.54)29.6817
2010's3 (23.08)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Abad-Santos, F; Almenara, S; Koller, D; Martín, S; Mejía, G; Navares-Gómez, M; Ochoa, D; Román, M; Romero-Palacián, D; Saiz-Rodríguez, M; Wojnicz, A; Zubiaur, P1
Cardiel-Sam, H; Shirk, DV; Wendel, N; Williams, SD1
Carson, WH; Cutler, AJ; Keck, PE; Marcus, RN; McQuade, RD; Orsulak, PJ; Sanchez, R; Torbeyns, A1
Cantrell, FL; Clark, RF; Shah, N; Young, MC1
Stip, E; Tourjman, V1
Ebrecht, M; Kungel, M; Messer, T; Modell, S; Schmauss, M; Spevakne-Goeroecs, T; Werner, C1
Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME1
Connor, KM; Davidson, JR; Gadde, KM; Payne, VM; Zhang, W1
Dobkin, RD; Marin, H; Menza, MA1
Auby, P; Manos, G; Marcus, RN; McQuade, RD; Oren, DA; Stock, E; Zimbroff, DL1
Loebel, A; Siu, C; Warrington, L; Yang, R; Zimbroff, D1
Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA1

Reviews

2 review(s) available for aripiprazole and Nausea

ArticleYear
Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Clinical therapeutics, 2010, Volume: 32 Suppl 1

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Nausea; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain; Young Adult

2010
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
    International journal of psychiatry in clinical practice, 2012, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2012

Trials

8 trial(s) available for aripiprazole and Nausea

ArticleYear
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial.
    Human psychopharmacology, 2021, Volume: 36, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Pressure; Dizziness; Electrocardiography; Female; Headache; Heart Rate; Humans; Male; Nausea; Olanzapine; Sleepiness

2021
Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
    Journal of affective disorders, 2009, Volume: 112, Issue:1-3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Headache; Humans; Lithium Compounds; Male; Middle Aged; Nausea; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Severity of Illness Index; Treatment Outcome; Weight Gain

2009
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:2 Pt 2

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Germany; Humans; Male; Nausea; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Sleep Initiation and Maintenance Disorders; Vomiting

2010
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Nausea; Obesity; Obsessive-Compulsive Disorder; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain

2005
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2007
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Acute Disease; Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Injections, Intramuscular; Lorazepam; Male; Nausea; Patient Dropouts; Piperazines; Psychomotor Agitation; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Vomiting

2007
Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Acute Disease; Adult; Affective Disorders, Psychotic; Antipsychotic Agents; Aripiprazole; Blood Glucose; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Electrocardiography; Fasting; Humans; Lipids; Nausea; Piperazines; Prolactin; Quinolones; Schizophrenia; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome; Weight Loss

2007
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Journal of affective disorders, 2008, Volume: 110, Issue:1-2

    Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome

2008

Other Studies

3 other study(ies) available for aripiprazole and Nausea

ArticleYear
    Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:5

    Topics: Angioedema; Antidepressive Agents; Anxiety; Aripiprazole; Black or African American; Child; Diphenhydramine; Histamine H1 Antagonists; Humans; Male; Nausea; Neck Pain

2021
Risk assessment of isolated aripiprazole exposures and toxicities: a retrospective study.
    Clinical toxicology (Philadelphia, Pa.), 2009, Volume: 47, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Child; Child, Preschool; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Dystonia; Female; Humans; Infant; Male; Middle Aged; Nausea; Piperazines; Poison Control Centers; Poisoning; Quinolones; Retrospective Studies; Risk Assessment; Tachycardia, Sinus; Vomiting; Young Adult

2009
Aripiprazole (Abilify) for schizophrenia.
    The Medical letter on drugs and therapeutics, 2003, Feb-17, Volume: 45, Issue:1150

    Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Dopamine Agonists; Drug Interactions; Fees, Pharmaceutical; Humans; Intestinal Absorption; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Therapeutic Equivalency

2003